Warning: You may find the images in this post uncomfortable. Needles and blood are shown. If you wish to just read the weekly update, scroll to the bottom of the page. As part of my cancer treatment, the oncologist requested that I get a Medi-Port installed. After an excruciating week post-treatment 1, I looked forward […]
MCL – PET Scan after Treatment 1
In an ideal world, I would have had this initial PET Scan before going into the first treatment. Between being in the hospital, the cancer moving quickly, insurance approvals, and scheduling – we weren’t going to get this particular test done until after treatment 1. The day before, they asked me to go on a […]
MCL Treatment 1 – Update
Each of the three Rituximab/Bendamustine treatments will be spread out over 2 days. Treatment 1 happened February 10 and 11. Day 1 is the long day – 8+ hours in the oncologists’ office sitting in a comfy chair as the oncologist and his staff manipulate bags of IV drugs. Day 2 is the short day […]
I Have Been Diagnosed with Cancer
On January 22, 2022 – I was diagnosed with Mantle Cell Lymphoma – Stage 4 Aggressive, TP53 expression. What this means – I get to go on the Cancer Patient journey.And that I probably don’t need to worry so much about retirement. I’m starting my first treatment on Thursday, February 10th. This initial phase looks […]
Presentation: Minding the Gap – Stakeholder Observation
On May 8th, I had a chance to speak at the University of Maryland’s Project Management Symposium. They did a brilliant job of pivoting from a live event to a 2-day virtual conference. Over 100 people watched this talk and at least 12 of them asked really solid questions. I could not have asked for […]
Video: Reaching Consensus
This talk describes my preferred way of reaching consensus – private 1:1 conversations with a group follow-up. Why do I prefer this approach when it seems so inefficient and time-consuming? I often get more honest answers. Everyone is heard – not just the loud or bossy or extroverted or high-status ones. And I get to […]
